267 related articles for article (PubMed ID: 28210622)
1. Epigenetics and Signaling Pathways in Glaucoma.
Gauthier AC; Liu J
Biomed Res Int; 2017; 2017():5712341. PubMed ID: 28210622
[TBL] [Abstract][Full Text] [Related]
2. Genes expressed in the human trabecular meshwork during pressure-induced homeostatic response.
Vittitow J; Borrás T
J Cell Physiol; 2004 Oct; 201(1):126-37. PubMed ID: 15281095
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of AAV transduction in glaucoma-associated human trabecular meshwork cells.
Borrás T; Xue W; Choi VW; Bartlett JS; Li G; Samulski RJ; Chisolm SS
J Gene Med; 2006 May; 8(5):589-602. PubMed ID: 16506246
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA‑93 is overexpressed and induces apoptosis in glaucoma trabecular meshwork cells.
Wang Y; Li F; Wang S
Mol Med Rep; 2016 Dec; 14(6):5746-5750. PubMed ID: 27878244
[TBL] [Abstract][Full Text] [Related]
5. Integrative transcriptomic and proteomic analysis reveals CD9/ITGA4/PI3K-Akt axis mediates trabecular meshwork cell apoptosis in human glaucoma.
Yan J; Yang X; Jiao X; Yang X; Guo M; Chen Y; Zhan L; Chen W
J Cell Mol Med; 2020 Jan; 24(1):814-829. PubMed ID: 31680442
[TBL] [Abstract][Full Text] [Related]
6. Trabecular meshwork as a new target for the treatment of glaucoma.
Ferrer E
Drug News Perspect; 2006 Apr; 19(3):151-8. PubMed ID: 16804567
[TBL] [Abstract][Full Text] [Related]
7. Genetic modification of human trabecular meshwork with lentiviral vectors.
Loewen N; Fautsch MP; Peretz M; Bahler CK; Cameron JD; Johnson DH; Poeschla EM
Hum Gene Ther; 2001 Nov; 12(17):2109-19. PubMed ID: 11747600
[TBL] [Abstract][Full Text] [Related]
8. Retinal ganglion cell apoptotic pathway in glaucoma: Initiating and downstream mechanisms.
Levkovitch-Verbin H
Prog Brain Res; 2015; 220():37-57. PubMed ID: 26497784
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection: A versatile approach to combat glaucoma.
Naik S; Pandey A; Lewis SA; Rao BSS; Mutalik S
Eur J Pharmacol; 2020 Aug; 881():173208. PubMed ID: 32464192
[TBL] [Abstract][Full Text] [Related]
10. Genomic and post-genomic effects of anti-glaucoma drugs preservatives in trabecular meshwork.
Izzotti A; La Maestra S; Micale RT; Longobardi MG; Saccà SC
Mutat Res; 2015 Feb; 772():1-9. PubMed ID: 25772104
[TBL] [Abstract][Full Text] [Related]
11. [Aiming for zero blindness].
Nakazawa T
Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress in the trabecular meshwork (Review).
Zhao J; Wang S; Zhong W; Yang B; Sun L; Zheng Y
Int J Mol Med; 2016 Oct; 38(4):995-1002. PubMed ID: 27572245
[TBL] [Abstract][Full Text] [Related]
13. Experimental glaucoma and optic nerve transection induce simultaneous upregulation of proapoptotic and prosurvival genes.
Levkovitch-Verbin H; Dardik R; Vander S; Nisgav Y; Kalev-Landoy M; Melamed S
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2491-7. PubMed ID: 16723461
[TBL] [Abstract][Full Text] [Related]
14. Effects of TGF-β2 on cadherins and β-catenin in human trabecular meshwork cells.
Wecker T; Han H; Börner J; Grehn F; Schlunck G
Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6456-62. PubMed ID: 24003087
[TBL] [Abstract][Full Text] [Related]
15. Newer targets for modulation of intraocular pressure: focus on adenosine receptor signaling pathways.
Agarwal R; Agarwal P
Expert Opin Ther Targets; 2014 May; 18(5):527-39. PubMed ID: 24579961
[TBL] [Abstract][Full Text] [Related]
16. Future possibilities in glaucoma therapy.
Wierzbowska J; Robaszkiewicz J; Figurska M; Stankiewicz A
Med Sci Monit; 2010 Nov; 16(11):RA252-9. PubMed ID: 20980972
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronan cable formation by ocular trabecular meshwork cells.
Sun YY; Keller KE
Exp Eye Res; 2015 Oct; 139():97-107. PubMed ID: 26247678
[TBL] [Abstract][Full Text] [Related]
18. Protecting the retinal neurons from glaucoma: lowering ocular pressure is not enough.
Pascale A; Drago F; Govoni S
Pharmacol Res; 2012 Jul; 66(1):19-32. PubMed ID: 22433276
[TBL] [Abstract][Full Text] [Related]
19. [New understanding and development of medical treatments for ocular diseases based upon molecular mechanisms].
Tanihara H
Nippon Ganka Gakkai Zasshi; 2005 Dec; 109(12):917-59; discussion 960-1. PubMed ID: 16408490
[TBL] [Abstract][Full Text] [Related]
20. Activation of Prostaglandin FP and EP2 Receptors Differently Modulates Myofibroblast Transition in a Model of Adult Primary Human Trabecular Meshwork Cells.
Kalouche G; Beguier F; Bakria M; Melik-Parsadaniantz S; Leriche C; Debeir T; Rostène W; Baudouin C; Vigé X
Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1816-25. PubMed ID: 27082296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
